Steve Glazer, M.D.

Steve Glazer, M.D. is Director of New Research Programs investigating the role of Bordetella pertussis infection in autoimmune, allergic and neurodegenerative disease. Dr. Glazer has published scientific papers on the pertussis hypothesis of multiple sclerosis, celiac disease and Alzheimer’s disease with Dr. Rubin. Dr. Glazer is board certified in internal medicine, and completed postgraduate training at New York Presbyterian/Cornell, Memorial Sloan Kettering Cancer Center, and was a fellow in General Internal Medicine at New York Presbyterian/Columbia. Dr. Glazer received his M.D. from Emory University and his B.A. from the University of Pennsylvania.

Copyright 2013-2024 ILiAD Biotechnologies